Identification of a new pyruvate kinase M2 isoform (PKM2) activator for the treatment of non-small-cell lung cancer (NSCLC). [electronic resource]
Producer: 20190819Description: 1851-1858 p. digitalISSN:- 1747-0285
- Antineoplastic Agents -- chemistry
- Apoptosis -- drug effects
- Binding Sites
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cell Line, Tumor
- Humans
- Isoenzymes -- chemistry
- Lung Neoplasms -- drug therapy
- Molecular Docking Simulation
- Protein Structure, Tertiary
- Pyruvate Kinase -- chemistry
- Sulfonamides -- chemistry
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.